top of page
End of year review 2025

Dynamic Duration Fund

This is a marketing communication for professional investors only. Capital at risk.

Past performance does not predict future returns.

In 2025, global fixed income and inflation markets were defined by macroeconomic instability, driven by geopolitical tensions, shifting monetary policy, and tariff uncertainty. The new US administration introduced fiscal unpredictability, coinciding with persistently elevated inflation in both the UK and US. 

Central banks began easing rates toward expected 3% terminal rates. The Federal Reserve (Fed) shifted its focus from price stability to employment, citing asymmetric risks and the transitory impact of tariffs, while maintaining independence from political interference. For the Bank of England (BoE), sticky prices, particularly for services, remained a key consideration. Both central banks explicitly highlighted tariff-related uncertainty when maintaining steady policy rates. 

The Atlantic House Dynamic Duration Fund's systematic, rules-based strategy aims to deliver capital growth by dynamically adjusting duration exposure. The strategy demonstrated resilience in 2025 through diversification across rate and inflation exposures and across UK and US markets. 

The fund’s core philosophy—dynamically allocating between interest rate swaps (rate exposure) and inflation swaps (pure inflation protection)—was frequently tested and proved effective. Inflation swap positions provided crucial offset when fixed income faced headwinds, affirming their negative correlation. For example, strong US rates swap performance in February was met with small, offsetting losses in inflation swap sleeves. In July, negative contributions from interest rate swaps were more than offset by gains in inflation exposures amid rising tariff-driven inflation expectations. Geographic diversification also supported returns, with strong US performance in March and August offsetting weaker UK results. Overall, the systematic process delivered a consistent and predictable path of performance. 

The fund’s duration positioning is systematic, derived from three signals: Inflation Trend, Real Yield, and Inflation Target. Each contributes a score (0 to 2) for a combined signal out of 6. A higher score favours bonds while a lower score favours inflation. 

The UK sleeve maintained a neutral signal of 3/6 throughout the year, reflecting the persistent nature of UK core inflation, moderate changes in headline inflation and high real yields. Core inflation is trending down steadily and by April 2026 should be well below the 3% threshold, thereby increasing fixed income exposure. 

The US sleeve experienced a key systematic adjustment and reversal, locking in a gain from the decline in nominal swap rates over the period: 

  1. Shift to 4/6 in April: US core inflation declined to 2.8% (March data), raising the Inflation Target signal from 0 to 1, and the combined signal from 3/6 to 4/6, substantially increasing fixed income duration to 10.4 years. 

  2. Reversion to 3/6 in September: Subsequently, US core inflation rose to 3.1%, reversing the Inflation Target signal back to 0, and the US combined signal reverted to 3/6. Rates duration reduced (to 8.1 years) while inflation duration increased (to 4.3 years). 

 

To improve operational efficiency, signal thresholds bands were introduced in April to reduce whipsaws and transaction costs. There were occasions in 2025 where this saved the fund from executing on marginal changes in information. 

Limits for the US and UK real rate signals (Signal 2) were also adjusted in March and October 2025. Aside from these and a minor averaging change to the inflation momentum input last year, the framework has remained unchanged since the fund’s launch. 

As 2025 concludes, both UK and US sleeves held neutral 3/6 combined signals, corresponding to 100% exposure to interest rate swaps and 50% to inflation swaps. 

This neutral configuration is advantageous given the persistent inflation backdrop. As of September, UK core CPI is 3.5% and US core CPI is 3.0%, while 10-year inflation swap rates remain historically low, implying little inflation risk premium built into prices. 

The fund’s systematic 50% allocation to inflation swaps acts as an inexpensive hedge. Should inflation reaccelerate, the fund's inflation swap positions are well-positioned to generate returns and provide diversification, perfectly positioning the fund for a potential stagflation scenario. 

  • This is a marketing communication. The fund is aimed at advised & discretionary market investors over the long term who have the capacity to tolerate a loss of the entire capital invested or the initial amount.

    A final investment decision should not be contemplated until the risks are fully considered. A comprehensive list of risk factors is detailed in the Risk Factors Section of the Prospectus and the Supplement of the fund and in the relevant key investor information document (KIID). A copy of the English version of the Supplement, the Prospectus, and any other offering document and the KIID can be viewed at www.atlantichousegroup.com and www.geminicapital.ie. A summary of investor rights associated with an investment in the fund is available in English at ww.gemincapital.ie.

    Please be aware that past performance is not indicative of future performance. The value of investments and income from them can go down as well as up, and you may get back less than originally invested.

    Counterparty Risk: The risk that a counterparty will not fulfil its payment obligation for a trade, contract or other transaction, on the due date. 

    Interest Rate Risk: The fund’s investments are sensitive to changes in interest rates.

    Operational Risk: The risk of direct or indirect loss resulting from inadequate or failed processes, people and systems including those relating to the safekeeping of assets or from external events. 

    Credit Risk: The risk the issuer of the bond fails to make interest or capital payments.

    Liquidity Risk: The risk that the fund may be unable to sell an investment readily at its fair market value. In extreme market conditions this can affect the fund’s ability to meet redemption requests upon demand. 

    Derivatives Risk: The fund is permitted to use certain types of financial derivatives to achieve its objective. The value of these investments can rise and fall depending on the value of the underlying instrument. There is also a risk that the counterparty to these derivatives fails to meet its obligations. 

    For full information on these and other risks, please refer to the fund prospectus and offering documents, including the KID or KIID, as applicable.

  • This is a marketing communication issued by Atlantic House Investments Limited and does not constitute or form part of any offer or invitation to buy or sell shares. It should be read in conjunction with the Fund’s Prospectus, key investor information document (“KIID”) or offering memorandum. Atlantic House Investments Limited is authorised and regulated by the Financial Conduct Authority FRN 931264. Atlantic House Investments Limited is a Private Limited Company registered in England and Wales, registered number 11962808. Registered Office: One Eleven Edmund Street, Birmingham. B3 2HJ.  

     

    The contents of this article are based upon sources of information believed to be reliable. Atlantic House Investments Limited has taken reasonable care to ensure the information stated is accurate. However, Atlantic House Investments Limited make no representation, guarantee or warranty that it is wholly accurate and complete.  

     

    This material may not be disclosed or referred to any third party or distributed, reproduced or used for any other purposes without the prior written consent of Atlantic House, any data provider and any other third party whose data is included herein and must be returned on request to Atlantic House and any copies thereof in whatever form destroyed.  

     

    A decision may be taken at any time to terminate the arrangements for the marketing of the Fund in any jurisdiction in which it is currently being marketed. Shareholders in affected EEA Member State will be notified of any decision to terminate marketing arrangements in advance and will be provided the opportunity to redeem their shareholding in the Company free of any charges or deductions for at least 30 working days from the date of such notification.  

     

    GemCap Investment Funds (Ireland) plc is authorised in Ireland by the Central Bank of Ireland pursuant to the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011 (S.I. No. 352 of 2011) (the “UCITS Regulations”), as amended.  

    Gemini Capital Management (Ireland) Limited, trading as GemCap, is a limited liability company registered under the registered number 579677 under Irish law pursuant to the Companies Act 2014 which is regulated by the Central Bank of Ireland. Its principal office is at Suites 22-26 Morrison Chambers, 32 Nassau Street, Dublin 2, D02 X598 and its registered office is at 7th Floor, Block A, One Park Place, Upper Hatch Street, Dublin 2, D02E762. GemCap acts as both management company and global distributor to GemCap Investment Funds (Ireland) plc. 

Bg_01.png

2023 Fund Reviews

Annual review video

Watch the end of year fund review video.

Watch >

Fund information

View our dedicated fund page.

Read  >

Insights

Read the latest insights from our experts.

Read  >

Capital is at risk.  Past performance does not predict future returns.

bottom of page